Cyclodextrin-based therapies, Okklo’s field of expertise, seem promising in the treatment of some of these orphan diseases. Therefore, we feel highly committed to contribute to the success of the Gordon Research Conference on Lysosomal Disease (with many other partners, including various patient advocacy groups). We do this by offering some financial support, but also by …
okklo life sciences will be participating in the upcoming 12th International Symposium on MPS and related diseases. This meeting will bring together some patients, their parents and families and professionals, providing a platform for sharing of information on all aspects of MPS and related disorders, in order to advance quality of care and treatment. The meeting will be held in …
June 2012 Alex Zwiers participated in CRS Nordic Chapter meeting on Drug Delivery and Targeting in Reykjavik, Iceland, June 3-5, 2012. The meeting was well attended and with a dedicated audience with a keen interest in novel (bio-medical) applications for cyclodextrins, this proved to be an excellent opportunity for okklo life sciences to strengthen relationships …
March 2012 Okklo life sciences was invited to attend to 6th B4B meeting organized in Frankfurt from March 9-11, 2012. Brains for Brain (B4B ) is an internationalTask Force on rare genetic diseases involving the brain. The task force is formed by outstanding scientists, clinicians and leaders in the neurological field, working together with biotech …